Press release
Antibiotic Class Emerges through Digestive Enzyme, find out more at 3rd Annual Superbugs and Superdrugs USA Conference
SMi Group is proud to announce the return of the Superbugs & Superdrugs USA conference to Iselin, NJ on the 12th and 13th November 2018.
This year’s event will discuss the issue of antibacterial resistance is becoming increasingly prevalent within the world of modern medicine. Difficult-to-treat pathogens create an incredibly real issue within clinical environments; and the problem needs to be addressed with novel treatments and the development of mechanisms which circumvent current therapeutic barriers.
The two-day event will explore the ever-growing need of informative and thought-provoking discussion, to address these industry issues, Superbugs & Superdrugs USA conference will offer a jam-packed agenda with presentations from key industry leaders and up-and-coming thinkers, within the field.
This year’s expert speaker line-up includes:
• William Weiss, Director of Pre-Clinical Services, University of North Texas Health Science Center
• Anthony Simon Lynch, Senior Scientific Director, Janssen Fellow & Incubator Leader, Janssen
• Brent Cezairliyan, Senior Scientist, Octagon Therapeutics
• Ian Friedland, Clinical Consultant, Ex-Chief Medical Officer, Achaogen
• Malcolm Thomas, CEO, Agile Sciences
• Daniel Pevear, Sr. Vice President of Biology and Grants Development, Venatorx Pharmaceuticals
• Joe Newman, Senior Director, Head of Biology, Tetraphase Pharmaceuticals
• David Huang, Chief Medical Officer, Motif BioSciences
• Antonio DiGiandoneico, Principal Scientist, MedImmune
• Mahmoud Ghannoum, Director of Center for Medical Mycology, Case Western Reserve University
• Stephen Barat, Head of Pre-Clinical and Early Clinical Development, SCYNEXIS Inc
• Christopher Ford, Group Leader, Microbiome Sciences of ID, Seres Therapeutics
• Mark Albrecht, Project Officer, HHS/ASPR/BARDA
• Laura Kovanda, Senior Director Global Development Project Leader, Astellas Pharma
• Plus many more…
The next annual instalment in the global series will feature a packed agenda that homes in on expert led approaches to exploring new technologies, novel methods and broadening an understanding of funding and regulation. It will also offer hands on training through carefully selected post-conference interactive workshops, taking place on November 14th.
Rapid Diagnostics for Drug Resistance: Are we there yet? - November 14th
David Perlin, Executive Director & Professor, Public Health Research Institute, Rutgers University
Avoiding the post antibiotic era: The challenges and solutions to successful commercialisation of new antibiotics
Adam Woodrow, CCO, Paratek & David Findlay, Managing Director, Morton Findlay & Associates Ltd
2018 Event Highlights:
• Learn about pathogen focused drug development
• Discover the best methods to overcome bacterial resistance through novel modes of action
• Discuss the state of developments within the anti-fungal space
• Develop an understanding of funding opportunities which support antibacterial research and development
• Gain insight into the new techniques through case-study examples of rapid diagnostic methods currently being used within the field
The latest conference brochure is now available to download on the event website, where you can also register online: www.superbugs-usa.com/openpr Book by Sept 28 and save $100
Interested in sponsoring, exhibiting or speaking at this event?
Contact Alia Malick, Director, on +44 (0)20 7827 6168 or email amalick@smi-online.co.uk
For media enquiries, contact Jinna Sidhu on +44 (0) 20 7827 0688 or hsidhu@smi-online.co.uk
Superbugs & Superdrugs USA
November 12 - 13, 2018 | New Jersey
Sponsored by SCYNEXIS
Follow us @SMIpharm
Tag us #smibugs
*Genetic Engineering & Biotechnology News
---- ENDS ----
About SMi Group: Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk
Registered & Head Office: Ground & First Floor 1 Westminster Bridge Road London, SE1 7XW Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Antibiotic Class Emerges through Digestive Enzyme, find out more at 3rd Annual Superbugs and Superdrugs USA Conference here
News-ID: 1218839 • Views: …
More Releases from SMi Group
Darren Green, GSK, conference chair invitation to attend 3rd Annual AI in Drug D …
SMi Reports: Conference Chairman Darren Green from GSK personally invites you the 3rd Annual AI in Drug Discovery Conference taking place on 14th and 15th March 2022 in London, UK.
The conference will have a focus on case studies from leading pharma and biotech firms, as well as a exploring the latest innovations in machine learning for enhancing discovery pipelines.
Darren Green, Director of Computational Chemistry at GSK will be chairing at…
Registration is open for SMi’s 5th Annual Pharmaceutical Microbiology East Coa …
SMi Group reports: The 5th Annual Pharmaceutical Microbiology East Coast Conference is set to return in April 2022 with a key focus existing methods and novel tools in microbial control to assure continuity in product quality and patient safety.
SMi Group is delighted to announce the 5th Annual Pharmaceutical Microbiology East Coast Conference, taking place on the 27th and 28th April 2022 in Boston, USA.
The 2022 Conference theme is…
SMi’s 10th Annual Pharmaceutical Microbiology UK Conference - A Virtual Confer …
SMi Reports: SMi Group have made the decision to open the microbiology conference and workshops to all microbiologists by transforming it into a virtual-remote online access event only on 17th and 18th January 2022.
SMi’s 10th Annual Pharmaceutical Microbiology UK Conference will no longer take place in London, UK. Instead, the conference is taking place on 17 and 18 January 2022 and will open its doors to a global audience delivering…
Co-chairs Philip Hewitt and Stefan Pryzyborski, invitation to join SMi’s 5th A …
SMi Group reports: Co-Chairs, Philip Hewitt and Stefan Pryzyborski for SMi’s 5th Annual 3D Cell Culture invite industry professionals to join the conference in February 2022.
Philip Hewitt, Global Head of Early Investigative Toxicology, Merck and Stefan Przyborski, Professor in Cell Technology, Durham University invite industry professionals by releasing invite letter to join SMi’s 5th Annual 3D Cell Culture Conference 2022.
This event will convene on February 9th – 10th 2022,…
More Releases for Director
Pridelines Appoints New Executive Director
Pridelines Announces Appointment of New Executive Director
Miami, FL - Pridelines, a leading LGBTQ non-profit organization dedicated to empowering, educating, and supporting the South Florida LGBTQ community, is thrilled to announce the appointment of our new Executive Director, Dr. Edward Summers.
Edward brings a wealth of experience and passion to Pridelines, having served as the Program Director and Primary Therapist at i-Kare Treatment Center in West Palm Beach, Florida, and Primary Therapist…
Wallace Associates: Director of Sales
Director of Sales
San Francisco, CA or New York, NY
The Company
Our client helps the world’s media, information, and technology providers grow revenue, deliver superior solutions, optimize their clients’ performance, and thrive in a fast-changing global digital market. Our client advances the business of information as a company “that works” — for each other, their clients, their stakeholders, and their community.
The Job
Our client is looking for a proven top-producer, entrepreneurial-minded, highly motivated,…
BLACK MOTH APPOINTS SALES DIRECTOR
Black Moth, provider of smart vision systems for heavy machinery, announced that Tony Clear has joined the company in the newly created role of Sales Director. Tony will be responsible for managing the sales strategy of the company, as well as increasing sales in Australia and New Zealand and developing new markets in North America and Europe.
Scott Gemmell, CEO of Black Moth, said: “With his solid track record and vast…
Songwon appoints KY Lee as Managing Director for Korea and Sales Director for No …
Ulsan, Korea – April 24, 2012 – KY Lee will join the Songwon team as Managing Director (상무, 'sangmoo') for Korea and Sales Director for North East Asia from the 2nd of May, 2012. Songwon Industrial Co. Ltd., the global number two supplier of polymer additives, has created this new key role within their Global Sales and Technical Service organization to reflect the importance of this key region and market.…
OGT Appoints New Finance Director
Oxford Gene Technology (OGT), provider of innovative clinical genetics and diagnostic solutions to advance molecular medicine, has today announced the appointment of a new finance director as part of the company’s ongoing rapid growth and expansion. Mr Tim Hall will join the company at the start of 2012 and brings a strong track record in financial management and strategic planning together with a broad knowledge of the biotech and healthcare…
Kirk Communications hires Creative Director
John Decker has joined Kirk Communications as Creative Director where he will head up TV, print, radio and web content production. Decker brings with him more than 30 years of advertising and copywriting experience. First, on Madison Ave. where he created memorable national advertising campaigns for Mercedes-Benz, Microsoft, Jaguar Cars and many others.
For the past decade he has been concentrating on web content, search engine optimization (SEO) and creating…
